Abstract
Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have